MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2013 Financial Results on Thursday, December 19, 2013

  MGC Diagnostics Corporation to Report Fourth Quarter and Fiscal Year 2013
               Financial Results on Thursday, December 19, 2013

PR Newswire

SAINT PAUL, Minn., Dec. 11, 2013

SAINT PAUL, Minn., Dec. 11, 2013 /PRNewswire/ --MGC Diagnostics Corporation
(NASDAQ: MGCD), a global medical technology company, today scheduled a
conference call to discuss its financial results for the fourth quarter and
fiscal year 2013, ended October 31, 2013. The call will be at 11:00 a.m. ET
on Thursday December 19, 2013. The Company will report financial results for
the fourth quarter and fiscal year 2013 before the markets open on Thursday,
December 19, 2013.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the
conference call, or listen via a live Internet webcast on the Company's
website at www.mgcdiagnostics.com. A replay of the conference call will be
available by dialing (877) 344-7529 or (412) 317-0088, confirmation code
10037949, through December 26, 2013. A webcast replay of the conference call
will be accessible on the Company's website at www.mgcdiagnostics.comfor 90
days.

About MGC Diagnostics
MGC Diagnostics Corporation (NASDAQ: MGCD), (formerly Angeion Corporation), is
a global medical technology company dedicated to cardiorespiratory health
solutions. The Company, through its subsidiary Medical Graphics Corporation,
develops, manufactures and markets non-invasive diagnostic systems. This
portfolio of products provides solutions for disease detection, integrated
care, and wellness across the spectrum of cardiorespiratory healthcare. The
Company's products are sold internationally through distributors and in the
United States through a direct sales force targeting heart and lung
specialists located in hospitals, university-based medical centers, medical
clinics, physicians' offices, pharmaceutical companies, medical device
manufacturers, and clinical research organizations (CROs). For more
information about MGC Diagnostics, visit www.mgcdiagnostics.com.

Contact: Wesley W. Winnekins         Joe Dorame, Robert Blum, Joe Diaz
         MGC Diagnostics Corporation Lytham Partners, LLC
         Chief Financial Officer     (602) 889-9700
         (651) 484-4874              mgcd@lythampartners.com

SOURCE MGC Diagnostics Corporation

Website: http://www.mgcdiagnostics.com
 
Press spacebar to pause and continue. Press esc to stop.